| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |